Baupost Group - CASCADIAN THERAPEUTICS INC ownership

CASCADIAN THERAPEUTICS INC's ticker is CASCXXXX and the CUSIP is 14740B101. A total of 77 filers reported holding CASCADIAN THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baupost Group ownership history of CASCADIAN THERAPEUTICS INC
ValueSharesWeighting
Q3 2016$41,000,000
+73.9%
25,000,0000.0%0.58%
+82.2%
Q2 2016$23,578,00025,000,0000.32%
Other shareholders
CASCADIAN THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
BVF INC/IL 18,799,368$17,730,0003.78%
Avoro Capital Advisors LLC 5,744,723$5,418,0001.20%
FT Options LLC 1,117,661$1,054,0000.90%
NEA Management Company, LLC 10,750,000$10,105,0000.52%
PERKINS CAPITAL MANAGEMENT INC 307,400$290,0000.33%
Baupost Group 25,000,000$23,578,0000.32%
Perceptive Advisors 3,414,121$3,220,0000.22%
Anson Funds Management LP 898,000$847,0000.16%
DAFNA Capital Management LLC 175,000$165,0000.13%
Telemetry Investments, L.L.C. 250,000$236,0000.13%
View complete list of CASCADIAN THERAPEUTICS INC shareholders